Clinical Trial Update: High Plasma Level of Long Pentraxin 3 is Associated With Insulin Resistance in Women With Polycystic Ovary Syndrome (PCOS)

View source ↗

Summary

A completed clinical trial reports an association between high plasma levels of long pentraxin 3 and insulin resistance in women with polycystic ovary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Snippet

Sponsor: Gulhane School of Medicine | Conditions: PCOS | Status: COMPLETED